(Q44887797)

7 December 2017

VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis (English)

1 reference

7 December 2017

0 references

0 references

0 references

Cong Dai

1

1 reference

7 December 2017

Chang-Qing Zheng

2

1 reference

7 December 2017

Fan-Ji Meng

3

1 reference

7 December 2017

Zheng Zhou

4

1 reference

7 December 2017

Li-Xuan Sang

5

1 reference

7 December 2017

Min Jiang

6

1 reference

7 December 2017

23 October 2012

1 reference

Molecular and Cellular Biochemistry

7 December 2017

1 reference

7 December 2017

374

1 reference

7 December 2017

1-11

1 reference

7 December 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-012-1488-3

7 December 2017

0 references

cites work

Tumor necrosis factor: a pleiotropic cytokine and therapeutic target

1 reference

12 December 2020

Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis

1 reference

12 December 2020

Colonic Mucosal Interleukin-6 in Inflammatory Bowel Disease

1 reference

12 December 2020

Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis

1 reference

12 December 2020

Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase

1 reference

12 December 2020

Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin.

1 reference

12 December 2020

Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis

1 reference

12 December 2020

Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation

1 reference

12 December 2020

A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice.

1 reference

12 December 2020

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

1 reference

12 December 2020

Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis.

1 reference

12 December 2020

New insights into IBD epidemiology: Are there any lessons for treatment?

1 reference

12 December 2020

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria

1 reference

12 December 2020

Effects of probiotic on intestinal mucosa of patients with ulcerative colitis

1 reference

12 December 2020

Biologic therapy of inflammatory bowel disease.

1 reference

12 December 2020

Therapeutic options to modulate barrier defects in inflammatory bowel disease

1 reference

12 December 2020

Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model

1 reference

12 December 2020

1 reference

12 December 2020

Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.

1 reference

12 December 2020

Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats

1 reference

12 December 2020

[Inflammatory bowel disease: longterm management]

1 reference

12 December 2020

Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase

1 reference

12 December 2020

Oxygen radicals in ulcerative colitis

1 reference

12 December 2020

The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis

1 reference

12 December 2020

Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid

1 reference

12 December 2020

VSL#3 and Remission in Active Ulcerative Colitis: Larger Studies Required

1 reference

12 December 2020

Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome

1 reference

12 December 2020

Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis

1 reference

12 December 2020

Pathology of inflammatory bowel disease

1 reference

12 December 2020

Multistep mechanism of probiotic bacterium, the effect on innate immune system

1 reference

12 December 2020

iNOS-mediated nitric oxide production and its regulation

1 reference

12 December 2020

Anti-inflammatory effects of Inonotus obliquus in colitis induced by dextran sodium sulfate.

1 reference

12 December 2020

Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease

1 reference

12 December 2020

Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells

1 reference

12 December 2020

The role of bacteria in the pathogenesis of inflammatory bowel disease

1 reference

12 December 2020

Lack of Interleukin-10 Leads to Intestinal Inflammation, Independent of the Time at Which Luminal Microbial Colonization Occurs

1 reference

12 December 2020

Effects of the Probiotic Formulation VSL#3 on Colitis in Weanling Rats

1 reference

12 December 2020

VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases

1 reference

12 December 2020

Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10.

1 reference

12 December 2020

Plant originated glycoprotein has anti-oxidative and anti-inflammatory effects on dextran sulfate sodium-induced colitis in mouse

1 reference

12 December 2020

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study.

1 reference

12 December 2020

Inflammatory bowel disease, gut bacteria and probiotic therapy

1 reference

12 December 2020

COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation.

1 reference

12 December 2020

UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis

1 reference

12 December 2020

Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

1 reference

12 December 2020

Functional effects of dextran sulphate sodium (DSS) treatment on the longitudinal muscle of rat distal colon

1 reference

12 December 2020

Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice

1 reference

12 December 2020

Cytokine profiles of cultured microvascular endothelial cells from the human intestine

1 reference

12 December 2020

Significance of interleukin-6 in patients with inflammatory bowel disease

1 reference

12 December 2020

Natural products as targeted modulators of the nuclear factor-kappaB pathway

1 reference

12 December 2020

VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study

1 reference

12 December 2020

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

1 reference

12 December 2020

Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene

1 reference

12 December 2020

Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling.

1 reference

12 December 2020

Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease

1 reference

12 December 2020

1 reference

12 December 2020

The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice

1 reference

12 December 2020

Recommendations for probiotic use.

1 reference

12 December 2020

Saccharomyces boulardii reduced intestinal inflammation in mice model of 2,4,6-trinitrobencene sulfonic acid induced colitis: based on microarray

1 reference

12 December 2020

Pathology of chronic inflammatory bowel disease in children

1 reference

12 December 2020

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

1 reference

12 December 2020

Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases

1 reference

12 December 2020

Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide

1 reference

12 December 2020

Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats.

1 reference

12 December 2020

Probiotics, Irritable Bowel Syndrome, and Inflammatory Bowel Disease.

1 reference

12 December 2020

10.1007/S11010-012-1488-3

Identifiers

DOI

1 reference

7 December 2017

1 reference